SCHEMBL15577005

SCHEMBL15577005

COCC1CCC(CO)C1

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.35
NR1H2 P55055 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25068750 1.00 EPHX2 (0.35) EPHX2NR1H2
SCHEMBL19445523 0.89 NR1H2 (0.35) NR1H2
SCHEMBL8616249 0.85 ESR1 (0.34)
SCHEMBL20511474 0.85 ESR1 (0.34)
SCHEMBL9406344 0.79 ESR1 (0.31) NR1H2
SCHEMBL9406353 0.79 ESR1 (0.31) NR1H2
SCHEMBL9406356 0.79 ESR1 (0.31) NR1H2
SCHEMBL18643686 0.79
SCHEMBL23136777 0.79
SCHEMBL62606 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8674095-B2 Compounds for treating neuropsychiatric conditions AFRAXIS HOLDINGS, INC. (US) 2014-03-18 US disclosed